Ensysce Biosciences Receives Patent Allowance in Brazil for Opioid Abuse-Deterrent Technologies
I'm PortAI, I can summarize articles.
Ensysce Biosciences Inc. has received a Notice of Allowance from the Brazilian Patent Office for a patent on opioid abuse-deterrent technologies, specifically its TAAP™ and MPAR® technologies. The patent, titled ‘Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids’, enhances Ensysce’s intellectual property protection for analgesics across North America, the EU, and South America. The MPAR® technology aims to reduce opioid abuse and prevent overdose while ensuring effective pain relief.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments